Table 1.
Comparison between ART-treated and ART-naïve groups
| Study characteristic | ART (n = 30) |
ART-naïve (n = 30) |
P value | ||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| Age (years) | 41.63 | 10.94 | 40.60 | 9.48 | 0.697 |
| Duration of disease (months) | 53.03 | 27.76 | 17.20 | 9.18 | <0.001 |
| Male/female | 23/7 | – | 21/9 | – | – |
| BMI (kg/m2) | 20.27 | 3.82 | 18.41 | 4.27 | 0.080+ |
| Waist circumference (cm) | 82.7 | 11.88 | 76.7 | 9.64 | 0.036 |
| Systolic BP (mm Hg) | 125.67 | 18.51 | 114.13 | 11.60 | 0.005 |
| Diastolic BP (mm Hg) | 80.60 | 9.13 | 75.60 | 8.23 | 0.030 |
| Fasting blood glucose (mg/dL) | 95 | 25.16 | 89.53 | 19.6 | 0.352 |
| Two-hour OGTT blood glucose (mg/dL) | 111.33 | 58.47 | 131.33 | 28.55 | 0.094 |
| HOMA | 2.50 | 2.68 | 1.80 | 1.93 | 0.265 |
| Total cholesterol (mg/dL) | 157.47 | 43.58 | 149.17 | 39.92 | 0.445 |
| HDL cholesterol (mg/dL) | 32.87 | 13.27 | 25.53 | 9.42 | 0.017 |
| LDL cholesterol (mg/dL) | 86.92 | 32.91 | 78.50 | 21.63 | 0.281 |
| Triglycerides (mg/dL) | 201.37 | 163.66 | 155.43 | 70.14 | 0.163 |
| CD-4 counts (cells/μL) | 210.23 | 172.89 | 170.67 | 131.40 | 0.322 |
Abbreviations: ART, antiretroviral therapy; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; HOMA, homeostasis assessment; LDL, low-density lipoprotein; OGTT, oral glucose tolerance test; SD, standard deviation.